![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Lipoxen | LSE:LPX | London | Ordinary Share | GB00B08NWV55 | ORD 0.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 7.875 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMLPX RNS Number : 8711P Lipoxen PLC 01 April 2009 1 April 2009 Lipoxen PLC ("Lipoxen" or the "Company") Change of Nominated Adviser and Joint Broker Lipoxen is pleased to announce the appointment of Singer Capital Markets as its Nominated Adviser and Joint Broker with immediate effect. Enquiries: +-------------------------------------+-------------------------------------+ | Lipoxen PLC | +44 (0) 20 7691 3583 | | M. Scott Maguire, Chief Executive | | | Officer | | | | | +-------------------------------------+-------------------------------------+ | Singer Capital Markets | +44 (0) 20 3205 7500 | | Jeff Keating / Claes Spång | | +-------------------------------------+-------------------------------------+ This information is provided by RNS The company news service from the London Stock Exchange END APPUASNRKOROOAR
1 Year Lipoxen Chart |
1 Month Lipoxen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions